Author:
Allaire Manon,Nault Jean-Charles
Reference10 articles.
1. The yin and yang of evasion and immune activation in HCC;Makarova-Rusher;J Hepatol,2015
2. Sorafenib in advanced hepatocellular carcinoma;Llovet;N Engl J Med,2008
3. Bayer’s regorafenib significantly improves overall survival in patients with unresectable liver cancer. http://www.news.bayer.com/baynews/baynews.nsf/id/Bayers-Regorafenib-Significantly-Improves-Overall-Survival-Patients-Unresectable-Liver-Cancer.
4. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer;Borghaei;N Engl J Med,2015
5. Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets;Schulze;Nat Genet,2015
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献